Eterna Therapeutics Inc. (ERNA )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ERNA
- Company Eterna Therapeutics Inc.
- Price $0.35
- Changes Percentage -2.17
- Change -0.0078
- Day Low $0.34
- Day High $0.36
- Year High $2.63
- Year Low $0.22
- Market Cap $18,238,019
- Price Avg 50 EMA (D) $0.38
- Price Avg 200 EMA (D) $1.32
- Exchange NASDAQ
- Volume 156,881
- Average Volume 11,475,615
- Open $0.34
- Previous Close $0.36
- EPS -8.31
- PE -0.04
- Earnings Announcement 2025-03-12 20:00:00
- Shares Outstanding $51,374,700
Company brief: ETERNA THERAPEUTICS INC. (ERNA )
- Healthcare
- Biotechnology
- Mr. Sanjeev Luther
- https://www.brooklynitx.com
- US
- N/A
- 08-29-1991
- US1140822099
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.